Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Danaher Corp
(NY:
DHR
)
233.60
USD
-3.45 (-1.45%)
Streaming Delayed Price
Updated: 12:41 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Danaher Corp
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Danaher CEO To Comment On Financial Performance
January 13, 2021
Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company's fourth quarter 2020 performance in a...
From
PR Newswire
Danaher To Present At J.P. Morgan Healthcare Conference
January 07, 2021
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at...
From
PR Newswire
Danaher Schedules Fourth Quarter 2020 Earnings Conference Call
January 07, 2021
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and lasting...
From
PR Newswire
Danaher Announces Executive Appointment
December 21, 2020
Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos...
From
PR Newswire
Beckman Coulter Launches the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
December 18, 2020
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
From
PR Newswire
Danaher announces leadership appointment
December 14, 2020
Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2021, its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher...
From
PR Newswire
Danaher Announces Quarterly Dividend
December 08, 2020
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on January 29, 2021 to holders...
From
PR Newswire
Companion Diagnostics Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
December 01, 2020
Tags
Reportedtimes
Extended Distribution
iCN Internal Distribution
From
iCrowdNewswire
Danaher To Present At Evercore ISI HealthCONx Conference
November 24, 2020
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020 at 8:50...
From
PR Newswire
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
November 23, 2020
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient's relative level of antibodies in response to a previous SARS-CoV-2 infection. The assay is an added tool to assess...
From
PR Newswire
Danaher To Present At Wolfe Research Healthcare Conference
November 16, 2020
Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Research Healthcare Conference on Thursday, November...
From
PR Newswire
Danaher Releases 2020 Sustainability Report
November 10, 2020
Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today published its 2020 Sustainability Report, highlighting key environmental, social and governance developments at the Company and...
From
PR Newswire
Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs
November 10, 2020
Assay has 99.9% specificity and 98.3% sensitivity at 15-30 days post-symptom onset and confirmed 95.5% positive predictive value when disease incidence is as low as 3%
From
PR Newswire
Global Whole Health Partners Corp. (GWHP) Announces It now offers the new FDA cleared “Fingerstick” for rapid COVID-19 test results in minutes
November 05, 2020
Tags
GWHP News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
October 28, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
October 28, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements
October 27, 2020
Cytiva launches new services for diagnostic developers and will establish new labs to meet the future needs of the industry. Cytiva Diagnostic Services will help developers bring point-of-care...
From
PR Newswire
Danaher Reports Third Quarter 2020 Results
October 22, 2020
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise noted.
From
PR Newswire
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
October 15, 2020
Large multi-center clinical trial is a collaborative effort between Beckman Coulter and academic partners at Massachusetts General Hospital, Johns Hopkins University School of Medicine and the...
From
PR Newswire
High Content Screening Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
October 14, 2020
Tags
Technology
From
AB Newswire
Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
October 09, 2020
Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
From
PR Newswire
Danaher Schedules Third Quarter 2020 Earnings Conference Call
October 07, 2020
Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, October 22, 2020 beginning at 8:00 a.m. ET and...
From
PR Newswire
Danaher Announces Redemption Of Senior Notes
October 06, 2020
Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it will redeem all of the €800,000,000 aggregate principal amount of 1.700% Senior Notes due 2022 (NYSE: DHR /22) issued by DH Europe...
From
PR Newswire
Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
October 06, 2020
Access SARS-CoV-2 IgG assay shows excellent agreement with surrogate virus neutralization test which identifies antibodies that block the interaction between virus and host cell receptor
From
PR Newswire
FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
October 01, 2020
The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients
From
PR Newswire
Danaher Announces Pricing Of Senior Notes Offering
September 29, 2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of $1,000,000,000 principal amount of 2.600% senior notes due 2050 at an offering price of 98.970% of the...
From
PR Newswire
Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test
September 29, 2020
Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season
From
PR Newswire
Correction Notice To Press Release Regarding Dividend Amount
September 25, 2020
Danaher Corporation (NYSE: DHR) (the "Company") announced today a correction to the previously announced quarterly cash dividend payable on its 5.00% Series B Mandatory Convertible Preferred Stock. As...
From
PR Newswire
Danaher Announces Quarterly Dividend
September 15, 2020
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on October 30, 2020 to holders...
From
PR Newswire
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
September 15, 2020
Based on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. The...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
